APOE genotype predicts AD and other dementia but not ischemic cerebrovascular disease

Neurology

Volumn 56, Issue 2, 2001, Pages 194-200

  Frikke Schmidt, R ^a   Nordestgaard, B G ^b,c   Thudium, D ^c   Moes Gronholdt M L ^a   Tybjaerg Hansen A ^a,c  

^a University of Copenhagen   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c BISPEBJERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; LIPID; LIPOPROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DEMENTIA; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RISK; PRIORITY JOURNAL; RISK FACTOR;

EID: 0035936607     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.56.2.194     Document Type: Article

References (52)

1. Nucleotide sequence and structure of the human apolipoprotein E gene
2. Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene
3. Type III hyperlipoproteinemia (dysbetalipoproteinemia): The role of apolipoprotein E in normal and abnormal lipoprotein metabolism
4. Apolipoprotein E as a risk factor for coronary heart disease: A genetic and molecular biology approach
5. Apolipoprotein E: Impact of cytoskeletal stability in neurons and the relationship to Alzheimer's disease
6. Apolipoprotein E alleles and risk of coronary disease. A metaanalysis
7. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
8. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease
9. Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease
10. Apolipoprotein E: Risk factor for Alzheimer's disease
11. Apolipoprotein E polymorphism and Alzheimer's disease
12. Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease. A case-control study
13. Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism
14. The relationship between apolipoprotein E, dementia, and vascular illness
15. ApoE allele frequencies in Alzheimer's disease, Lewy body dementia, Alzheimer's disease with cerebrovascular disease and vascular dementia
16. Apolipoprotein E, dementia, and cortical deposition of β-amyloid protein
17. Apolipoprotein E polymorphism, Alzheimer's disease and vascular dementia among elderly Finnish men
18. The apolipoprotein E gene in Binswanger's disease and vascular dementia
19. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study
20. Plasma apolipoproteins in patients with multi-infarct dementia
21. Apolipoprotein E genotypes and serum lipid levels in Alzheimer's disease and multi-infarct dementia
22. The role of apolipoprotein E in the nervous system
23. A book of tables with data from the first examination (1976-78) and a five year follow-up (1981-83)
24. Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease
25. ACE gene polymorphism as a risk factor for ischemic cerebrovascular disease
26. Does color-flow imaging improve the accuracy of duplex carotid evaluation?
27. Primary prevention of transient ischemic attack and thromboembolic stroke
28. Mini-Mental State. A practical method for grading the cognitive state of patients for the clinician
29. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia
30. Cerebral blood flow in dementia
31. Mini-compendium of rating scales for states of anxiety, depression, mania, schizophrenia with corresponding DSM-III syndromes
32. The global deterioration scale for assessment of primary degenerative dementia
33. Diagnostic and statistical manual of mental disorders. 3rd rev ed
34. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease
35. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI
36. Measures of disease frequency and association
37. Are risk factors for stroke and coronary disease the same?
38. Cholesterol, diastolic blood pressure, and stroke: 13000 Strokes in 450000 people in 45 prospective cohorts
39. Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: The Copenhagen City Heart Study
40. Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects
41. Apolipoprotein E genotyping in Alzheimer's disease
42. Phenotype-dependent differences in apolipoprotein E metabolism and in cholesterol homeostasis in human monocyte-derived macrophages
43. Brain infarction and the clinical expression of Alzheimer disease
44. Apolipoprotein E ε4 and the risk of dementia with stroke. A population-based investigation
45. The neuropathology of Alzheimer's disease: Diagnostic features and standardization
46. β-Amyloid-mediated vasoactivity and vascular endothelial damage
47. Vascular dementia: Diagnostic criteria for research studies
48. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers
49. Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia